Previous Article | Next Article 
Journal of Virology, June 2002, p. 6408-6412, Vol. 76, No. 12
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.12.6408-6412.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Pre- and Postexposure Prophylaxis of Ebola Virus Infection in an Animal Model by Passive Transfer of a Neutralizing Human Antibody
Paul W. H. I. Parren,1,
Tom W. Geisbert,2 Toshiaki Maruyama,1,
Peter B. Jahrling,2* and Dennis R. Burton1*
Departments of Immunology and Molecular Biology, The Scripps Research Institute, La Jolla, California 92037,1
U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 217022
Received 12 October 2001/
Accepted 8 March 2002
A neutralizing human monoclonal antibody, KZ52, protects guinea pigs from lethal Ebola Zaire virus challenge. Administration before or up to 1 h after challenge resulted in dose-dependent protection by the antibody. Interestingly, some antibody-treated animals survived despite developing high-level viremia, suggesting that the mechanism of protection by KZ52 may extend beyond reduction of viremia by virus neutralization. KZ52 is a promising candidate for immunoprophylaxis of Ebola virus infection.
* Corresponding author: Mailing address for Dennis R. Burton: Department of Immunology, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037. Phone: (858) 784-9298. Fax: (858) 784-8360. E-mail:
burton{at}scripps.edu. Mailing address for Peter B. Jahrling: Headquarters, USAMRIID, Ft. Detrick, Frederick, MD 21702. Phone: (301) 619-2772. Fax: (301) 619-4625. E-mail:
Peter.Jahrling{at}DET.AMEDD.ARMY.MIL.
Present address: Genmab, Utrecht, The Netherlands.
Present address: Alexion Antibody Technologies, San Diego, CA 92121.
Journal of Virology, June 2002, p. 6408-6412, Vol. 76, No. 12
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.12.6408-6412.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Prabhu, N., Prabakaran, M., Ho, H.-T., Velumani, S., Qiang, J., Goutama, M., Kwang, J.
(2009). Monoclonal Antibodies against the Fusion Peptide of Hemagglutinin Protect Mice from Lethal Influenza A Virus H5N1 Infection. J. Virol.
83: 2553-2562
[Abstract]
[Full Text]
-
Hunt, A. R., Frederickson, S., Hinkel, C., Bowdish, K. S., Roehrig, J. T.
(2006). A humanized murine monoclonal antibody protects mice either before or after challenge with virulent Venezuelan equine encephalomyelitis virus. J. Gen. Virol.
87: 2467-2476
[Abstract]
[Full Text]
-
Warfield, K. L., Olinger, G., Deal, E. M., Swenson, D. L., Bailey, M., Negley, D. L., Hart, M. K., Bavari, S.
(2005). Induction of Humoral and CD8+ T Cell Responses Are Required for Protection against Lethal Ebola Virus Infection. J. Immunol.
175: 1184-1191
[Abstract]
[Full Text]
-
Sullivan, N., Yang, Z.-Y., Nabel, G. J.
(2003). Ebola Virus Pathogenesis: Implications for Vaccines and Therapies. J. Virol.
77: 9733-9737
[Full Text]
-
Mpandi, M., Otten, L. A., Lavanchy, C., Acha-Orbea, H., Finke, D.
(2003). Passive Immunization with Neutralizing Antibodies Interrupts the Mouse Mammary Tumor Virus Life Cycle. J. Virol.
77: 9369-9377
[Abstract]
[Full Text]
-
HAN, S. Z., ALFANO, M. C., PSOTER, W. J., REKOW, E. D.
(2003). Bioterrorism and catastrophe response: A quick-reference guide to resources. Journal of the American Dental Association
134: 745-752
[Abstract]
[Full Text]